ArticleInternational journal of nanomedicine2026
Size-Dependent Layered Double Hydroxide Nanoparticles Promote Osteogenesis and Bone Regeneration via METTL3-Dependent N6-Methyladenosine Modification of Runx2 mRNA.
Article in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MgFe-Layered Double Hydroxide-Reinforced Injectable GelMA Hydrogels Promote Calvarial Bone Regeneration with IL-10RA-JAK1-STAT3-Associated Osteoimmunomodulation.International journal of nanomedicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The osteogenic efficacy of mesenchymal stem cell (MSC)-based bone regeneration is often limited by insufficient osteogenic differentiation. Layered double hydroxide (LDH) nanoparticles are promising biomaterials, but whether their intrinsic osteoinductive activity is regulated by particle size and epitranscriptomic mechanisms remains unclear. This study investigated whether LDH nanoparticles promote osteogenesis in bone marrow-derived MSCs (BMSCs) through METTL3-dependent N6-methyladenosine (m6A) modification. Methods: BMSCs were treated with 50 nm or 100 nm LDH nanoparticles under osteogenic induction. Osteogenic differentiation was evaluated by alkaline phosphatase activity, mineralization staining, osteogenic gene/protein expression, and cytoskeletal morphology. Global m6A levels and m6A regulator expression were assessed, and the role of METTL3 was examined using Mettl3 knockdown. Runx2 mRNA m6A enrichment and stability were analyzed by MeRIP-qPCR and actinomycin D chase assays. Bone regeneration was further evaluated using a GelMA-LDH hydrogel in a murine calvarial defect model. Results: LDH nanoparticles promoted BMSC osteogenesis in a size-dependent manner, with 100 nm LDH producing stronger ALP activity, mineralization, and osteogenic marker expression than 50 nm LDH. Mechanistically, 100 nm LDH increased global m6A methylation and selectively upregulated METTL3. Mettl3 knockdown markedly impaired osteogenesis and abolished the pro-osteogenic effects of LDH. LDH enhanced m6A modification of Runx2 mRNA and prolonged Runx2 transcript stability, thereby supporting RUNX2-mediated osteogenic programming. In vivo, GelMA-LDH implantation significantly enhanced calvarial bone repair and increased RUNX2 and METTL3 expression within defect regions. Conclusion: Among the two tested particle sizes, 100 nm LDH nanoparticles exhibited superior pro-osteogenic activity and promoted bone regeneration through a METTL3-dependent m6A mechanism that stabilizes Runx2 mRNA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.